CareLit · DOI-Nachweis · Klinische Pädiatrie
A Risk Adapted, Response- Based Therapeutic Regimen Using OEPA/COPDAC for the Treatment of Children with High Risk Hodgkin Lymphoma; from the Central American y Dominican Republic Group
DOI 10.1055/s-0034-1371136
Bibliografische Angaben
Nachweis in CareLit
Autor:innenE Castellanos, A Peña, S Alabi, F Baez, J Gamboa, M Metzger, P De Alarcon
ZeitschriftKlinische Pädiatrie
Ausgabe03/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Purpose: Childhood Hodgkin lymphoma (HL) is highly curable in high income countries. Our previous protocol with a modified Stanford V achieved an event- and overall-survival of 50% and 60% respectively. Here we present the follow up study for high risk patients using OE*PA/COPDAC. Method: Patients received 2 cycles of OE*PA (vincristine, etoposide, prednisone, and doxorubine) and 4 cycles of COPDAC (cyclophosphamide…
Zitieren
Zitierempfehlung
E Castellanos, A Peña, S Alabi, F Baez, J Gamboa, M Metzger, P De Alarcon (2014) A Risk Adapted, Response- Based Therapeutic Regimen Using OEPA/COPDAC for the Treatment of Children with High Risk Hodgkin Lymphoma; from the Central American y Dominican Republic Group. Klinische Pädiatrie (03). https://doi.org/10.1055/s-0034-1371136
Mit CareLit weiterarbeiten